Lidds AB logo

LIDDS - Lidds AB Share Price

SEK12.18 -0.3  -2.6%

Last Trade - 12:13pm

Micro Cap
Market Cap £31.2m
Enterprise Value £29.3m
Revenue £80.1k
Position in Universe 1246th / 1845
Unlock LIDDS Revenue
Relative Strength (%)
1m +16.2%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -34.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 1.03 7.75 0.000 0.35 61.0 7.00
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 31 March 2021, Lidds ABrevenues increased from SEK0K to SEK606K. Net lossincreased 35% to SEK10.8M. Revenues reflect an increase indemand for the Company's products and services due tofavorable market conditions. Higher net loss reflects Otherexternal expenses increase of 43% to SEK9.5M (expense),Staff costs increase of 49% to SEK1.8M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


LIDDS Revenue Unlock LIDDS Revenue

Net Income

LIDDS Net Income Unlock LIDDS Revenue

Normalised EPS

LIDDS Normalised EPS Unlock LIDDS Revenue

PE Ratio Range

LIDDS PE Ratio Range Unlock LIDDS Revenue

Dividend Yield Range

LIDDS Dividend Yield Range Unlock LIDDS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
LIDDS EPS Forecasts Unlock LIDDS Revenue
Profile Summary

Lidds AB (LIDDS) is a Sweden-based company engaged in the development of pharmaceutical products. LIDDS (Local Intelligent Drug Delivery System) uses its drug delivery technology, a parenteral, microparticulate drug carrier matrix, which is administered as a paste that spreads in the tissue and ultimately cures shortly after injection, allowing local treatment at site of disease. It targets primarily solid tumors. The Company’s portfolio includes Liproca Depot, aimed at prostate cancer with possible applications in benign prostate hypertrophy (BPH). The Liproca Depot is a bioresorbable, biocompatible and locally injectable modified release formulation of 2-hydroxyflutamid, prepared as a paste prior to injection.

Last Annual December 31st, 2020
Last Interim March 31st, 2021
Public Since July 31, 2014
No. of Shareholders: n/a
No. of Employees: 3
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange OMX Nordic Exchange Stockholm
Shares in Issue 29,675,316
Free Float (0.0%)
Eligible for
LIDDS Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for LIDDS
Upcoming Events for LIDDS
Wednesday 18th August, 2021 Estimate
Q2 2021 Lidds AB Earnings Release
Wednesday 17th November, 2021 Estimate
Q3 2021 Lidds AB Earnings Release
Frequently Asked Questions for Lidds AB
What is the Lidds AB share price?

As of 12:13pm, shares in Lidds AB are trading at SEK12.18, giving the company a market capitalisation of £31.2m. This share price information is delayed by 15 minutes.

How has the Lidds AB share price performed this year?

Shares in Lidds AB are currently trading at SEK12.18 and the price has moved by -5.3% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Lidds AB price has moved by -23.22% over the past year.

What are the analyst and broker recommendations for Lidds AB?

Of the analysts with advisory recommendations for Lidds AB, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Lidds AB is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Lidds AB next release its financial results?

Lidds AB is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-03-31
What is the Lidds AB dividend yield?

Lidds AB does not currently pay a dividend.

Does Lidds AB pay a dividend?

Lidds AB does not currently pay a dividend.

When does Lidds AB next pay dividends?

Lidds AB does not currently pay a dividend.

How do I buy Lidds AB shares?

To buy shares in Lidds AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Lidds AB?

Shares in Lidds AB are currently trading at SEK12.18, giving the company a market capitalisation of £31.2m.

Where are Lidds AB shares listed? Where are Lidds AB shares listed?

Here are the trading details for Lidds AB:

Country of listing: Sweden
Exchange: STO
Ticker Symbol: LIDDS
What kind of share is Lidds AB?

Based on an overall assessment of its quality, value and momentum, Lidds AB is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Lidds AB share price forecast 2021?

Shares in Lidds AB are currently priced at SEK12.18. At that level they are trading at 0.137% discount to the analyst consensus target price of 0.00.

Analysts covering Lidds AB currently have a consensus Earnings Per Share (EPS) forecast of 1.94 for the next financial year.

How can I tell whether the Lidds AB share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Lidds AB. Over the past six months, the relative strength of its shares against the market has been -25.42%. At the current price of SEK12.18, shares in Lidds AB are trading at -9.19% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Lidds AB PE Ratio?

We were not able to find PE ratio data for Lidds AB.

Who are the key directors of Lidds AB?

Lidds AB's management team is headed by:

Niklas Axen - OTH
Stefan Gruden - OTH
Carl-Gustaf Golander - OTH
Jan Tornell - CHM
Anders Bjartell - DRC
Ingalill Forslund Larsson - DRC
Maria Forss - DRC
Anna Torner - OTH
Daniel Lifveredson - DRC
Markus Thor - VBD
Charlotta Gauffin - OTH
David Bejker - DRC
Anja Peters Ohlsson - CFO
Nina Herne - CEO
Who are the major shareholders of Lidds AB?

Here are the top five shareholders of Lidds AB based on the size of their shareholding:

Wikow Venture AB Corporation
Percentage owned: 6.71% (2.28m shares)
Lifveredson (Daniel) Individual Investor
Percentage owned: 6.49% (2.21m shares)
Sporre (Bengt) Individual Investor
Percentage owned: 3.06% (1.04m shares)
Kilander (Ulf Richard) Individual Investor
Percentage owned: 2.53% (861k shares)
Berger (Gunvald) Individual Investor
Percentage owned: 1.93% (655k shares)
Similar to LIDDS
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.